Phase II Study of BKM120 in Men With Metastatic Castration-Resistant Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 May 2017
At a glance
- Drugs Buparlisib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 22 Feb 2017 Status changed from active, no longer recruiting to discontinued.
- 02 Jun 2015 Primary endpoint (Progression free survival) has not been met, according to abstract presented at ASCO 2015.